Sign In
Last checked at 
30 Jul 2009 07:00
ο»Ώ
Thursday 30 July 2009
Allergy Therapeutics plc
("Allergy Therapeutics" or "the Company")
Total Voting RightsΒ
Β
Β
Β
Allergy Therapeutics plc (AIM: AGY), the specialist pharmaceutical company focused on allergy vaccination, announces that the Company's share capital consists of 276,498,551 Ordinary 0.1p shares with voting rights attached (one vote per Ordinary share). The Company has no shares in Treasury therefore the total number of voting rights in Allergy Therapeutics is 276,498,551.Β
Β
The above total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, Allergy Therapeutics under the FSA's Disclosure and Transparency Rules.Β
Β
For further information
|
Allergy Therapeutics |
+44 (0) 1903 845 820 |
|
Keith Carter, Chief Executive |
|
|
www.allergytherapeutics.com |
|
|
Nomura Code Securities |
+44 (0) 207 776 1200 |
|
Juliet Thompson/ Clare Terlouw |
|
|
Financial Dynamics |
+44 (0) 207 831 3113 |
|
Ben Brewerton/Β Susan Quigley |
Follow the stocks
